Abstract:
A 13-year-old female experienced a recurrence of baclofen pump-related central nervous system (CNS) infection caused by Achromobacter, despite absence of retained foreign material.
[ctt tweet=”ReTweet if useful… Case study of extended-infusion Meropenem treatment http://ctt.ec/p3DTl+ @ivteam #ivteam” coverup=”p3DTl”]
Due to the failure of meropenem (120 mg/kg/d in divided doses every 8 hours and infused over 30 minutes) in the initial infection, the dose was infused over 4 hours during the recurrence. Meropenem is an antibiotic for which efficacy is time dependent, and 4-hour versus 30-minute infusions have been shown to prolong the time the concentration of the antibiotic exceeds the minimum inhibitory concentration (MIC) of the organism at the site of infection (T>MIC). Meropenem serum concentrations were obtained and indicated that T>MIC was at least 75% of the dosing interval. Our patient improved with no noted recurrences or adverse effects on the extended-infusion meropenem regimen. Utilization of extended-infusion beta-lactam dosing whenever possible in the treatment of serious infections caused by gram-negative organisms should be considered, as this dosing appears to be safe and improves the probability of achieving pharmacokinetic/pharmacodynamic goals.
Reference:
Nichols, K.R., Knoderer, C.A., Jackson, N.G., Manaloor, J.J. and Christenson, J.C. (2015) Success With Extended-Infusion Meropenem After Recurrence of Baclofen Pump-Related Achromobacter Xylosoxidans Meningitis in an Adolescent. Journal of Pharmacy Practice. 28(4), p.430-3.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]